ArticleJournal of hepatocellular carcinoma2023

Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab.

Yongqiang Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.